Vanguard Capital Management’s LB Pharmaceuticals LBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$42.2M Buy
1,099,880
+128,715
+13% +$5.32M ﹤0.01% 1983
2026
Q2
$31.5M Buy
971,165
+76,512
+9% +$2.25M ﹤0.01% 2188
2026
Q1
$22.1M Buy
+894,653
New +$20.6M ﹤0.01% 2288

Other funds holding LBRX

Vanguard Capital Management's LBRX Position: Q3 2026 in Review

Vanguard Capital Management increased its LB Pharmaceuticals (LBRX) stake by 13% in Q3 2026, buying an estimated $5.32M and bringing the position to 1,099,880 shares worth $42.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1983.

Vanguard Capital Management first reported a position in LBRX in Q1 2026 and has held it in 3 quarters since. 147 funds tracked by Wall St. Rank hold LBRX as of Q3 2026.

  • Vanguard Capital Management held 1,099,880 shares of LB Pharmaceuticals worth $42.2M as of Q3 2026.
  • Vanguard Capital Management bought 128,715 LB Pharmaceuticals shares in Q3 2026, an estimated $5.32M.
  • LB Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1983 holding.
  • Vanguard Capital Management first reported a position in LB Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 147 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.